Earnings Outlook For Syndax Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Syndax Pharmaceuticals (NASDAQ:SNDX) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.78. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $14.08, down 37.35% over the last 52-week period.
November 01, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Syndax Pharmaceuticals is expected to report an EPS of $-0.78 in its upcoming earnings. The stock has been on a downward trend, down 37.35% over the last year.
The company's stock has been on a downward trend, which may continue if the earnings report is not positive. The estimated EPS is negative, which could further impact the stock negatively. However, if the company beats the estimate and provides positive guidance, the stock could see a positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100